Study Details
Full Title
A multicentre, randomised, double-blind, placebo-controlled 52 week, Phase IIIb trial to evaluate the efficacy and safety of survodutide in peri- and post menopausal women with overweight or obesity (SYNCHRONIZE-HERA)
Principal Investigator
Mustafa
Bashir
Protocol Number
PRO00120627
Phase
N/A
Enrollment Status
Open to Enrollment